Akslen LA - Search Results

1

Age-related phenotypes in breast cancer: A population-based study.

Svanøe AA, Humlevik ROC, Knutsvik G, Sæle AKM, Askeland C, Ingebriktsen LM, Hugaas U, Kvamme AB, Tegnander AF, Krüger K, Davidsen B, Hoivik EA, Aas T, Stefansson IM, Akslen LA, Wik E. Svanøe AA, et al. Among authors: akslen la. Int J Cancer. 2024 Jun 1;154(11):2014-2024. doi: 10.1002/ijc.34863. Epub 2024 Feb 6. Int J Cancer. 2024. PMID: 38319154

2

Co-expression of the genes encoding transforming growth factor-alpha and its receptor in papillary carcinomas of the thyroid.

Aasland R, Akslen LA, Varhaug JE, Lillehaug JR. Aasland R, et al. Among authors: akslen la. Int J Cancer. 1990 Sep 15;46(3):382-7. doi: 10.1002/ijc.2910460308. Int J Cancer. 1990. PMID: 1697567

3

Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway.

Akslen LA, Haldorsen T, Thoresen SO, Glattre E. Akslen LA, et al. Cancer Res. 1991 Feb 15;51(4):1234-41. Cancer Res. 1991. PMID: 1997164

4

Incidence pattern of thyroid cancer in Norway: influence of birth cohort and time period.

Akslen LA, Haldorsen T, Thoresen SO, Glattre E. Akslen LA, et al. Int J Cancer. 1993 Jan 21;53(2):183-7. doi: 10.1002/ijc.2910530202. Int J Cancer. 1993. PMID: 8425755

5

Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.

Akslen LA, Varhaug JE. Akslen LA, et al. Cancer. 1995 Nov 1;76(9):1643-54. doi: 10.1002/1097-0142(19951101)76:9<1643::aid-cncr2820760922>3.0.co;2-#. Cancer. 1995. PMID: 8635070

6

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients.

Aas T, Børresen AL, Geisler S, Smith-Sørensen B, Johnsen H, Varhaug JE, Akslen LA, Lønning PE. Aas T, et al. Among authors: akslen la. Nat Med. 1996 Jul;2(7):811-4. doi: 10.1038/nm0796-811. Nat Med. 1996. PMID: 8673929

7

Independent prognostic importance of vascular invasion in nodular melanomas.

Straume O, Akslen LA. Straume O, et al. Among authors: akslen la. Cancer. 1996 Sep 15;78(6):1211-9. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.0.CO;2-C. Cancer. 1996. PMID: 8826942

8

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer.

Paulsen T, Aas T, Børresen AL, Varhaug JE, Lønning PE, Akslen LA. Paulsen T, et al. Among authors: akslen la. Int J Cancer. 1997 Feb 20;74(1):138-40. doi: 10.1002/(sici)1097-0215(19970220)74:1<138::aid-ijc23>3.0.co;2-a. Int J Cancer. 1997. PMID: 9036883 No abstract available.

9

Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome.

Aas T, Geisler S, Paulsen T, Børresen-Dale AL, Varhaug JE, Lønning PE, Akslen LA. Aas T, et al. Among authors: akslen la. Acta Oncol. 1996;35 Suppl 5:5-8. doi: 10.3109/02841869609083960. Acta Oncol. 1996. PMID: 9142957

10

Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma.

Straume O, Akslen LA. Straume O, et al. Among authors: akslen la. Int J Cancer. 1997 Oct 21;74(5):535-9. doi: 10.1002/(sici)1097-0215(19971021)74:5<535::aid-ijc10>3.0.co;2-5. Int J Cancer. 1997. PMID: 9355977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters